Register Log In Login with facebook

Pancreatic cancer risk of death reduced 19 percent by Vitamin D – meta-analysis June 2017

Plasma 25-hydroxyvitamin D levels, vitamin D intake, and pancreatic cancer risk or mortality: a meta-analysis.

Oncotarget. 2017 Jun 29. doi: 10.18632/oncotarget.18888. [Epub ahead of print]
Zhang X1, Huang XZ1, Chen WJ1, Wu J1, Chen Y2, Wu CC1, Wang ZN3.

VitaminDWiki Summary

21% reduction in deaths, but no reduction in occurrence (study on this page)

That is, high Vitamin D blood level does not change who gets pancreatic caner, but it does increase survival

Note: Like many other diseases, how much vitamin D actually gets to the cells is far more important that how much is in blood

See also VitaminDWiki

Vitamin D Receptor category has the following

173 items in Vitamin D Receptor category

Vitamin D tests cannot detect Vitamin D Receptor (VDR) problems
A poor VDR restricts Vitamin D from getting in the cells
A poor VDR increases the risk of 37 health problems  click here for details

VDR at-home test $29 - results not easily understood in 2016
There are hints that you may have inherited a poor VDR
You can compensate for poor VDR by increasing one or more of the following:

1) Vitamin D supplement
  Sun, Ultraviolet -B
Vitamin D in the blood
and thus to the cells
2) MagnesiumVitamin D in the blood
 AND to the cells
3) Omega-3 Vitamin D to the cells
4) Resveratrol Vitamin D to the cells
5) Intense exercise Vitamin D Receptor
6) Get prescription for VDR activator
   paricalcitol, maxacalcitol?
Vitamin D Receptor
7) Quercetin (flavonoid) Vitamin D Receptor

Genetics category listing contains the following

Many genes are NOT noticed by Vitamin D blood tests

 Download the PDF from VitaminDWiki

Pancreatic cancer MORTALITY


Pancreatic cancer INCIDENCE


The associations between vitamin D status, including plasma 25-hydroxyvitamin D [25(OH)D] levels and vitamin D intake, and pancreatic cancer risk and mortality are inconsistent. The aims of this study are to evaluate the antitumor and therapeutic effects of vitamin D status for pancreatic cancer patients.

A literature search for relevant studies was conducted using PubMed and Embase databases. Risk ratio (RR), hazard ratio (HR), and 95% confidence interval (CI) were used as the effect measures. All statistical analyses were performed using Stata software 12.0.

Our results indicated that high plasma 25(OH)D levels were inversely associated with pancreatic cancer mortality without significant heterogeneity (HR=0.81, 95% CI=0.68-0.96). However, high plasma 25(OH)D levels could not reduce pancreatic cancer risk (RR=1.02, 95% CI=0.66-1.57). Moreover, vitamin D intake was also not associated with pancreatic cancer risk (RR=1.11, 95% CI=0.67-1.86)

Conclusions: Our results indicate that high plasma 25(OH)D levels were significantly associated with improved survival in pancreatic cancer patients. However, there were no significant associations between vitamin D intake or plasma 25(OH)D levels and pancreatic cancer risk.

PMID: 28733547 DOI: 10.18632/oncotarget.18888

Created by admin. Last Modification: Tuesday July 25, 2017 16:09:08 UTC by admin. (Version 9)

Attached files

ID Name Comment Uploaded Size Downloads
8209 PC risk.jpg admin 25 Jul, 2017 15:27 41.87 Kb 69
8208 PC mortality.jpg admin 25 Jul, 2017 15:27 38.21 Kb 58
8207 pancreatic cancer mortality.pdf PDF 2017 admin 25 Jul, 2017 15:26 1.81 Mb 35
See any problem with this page? Report it to the webmaster.